{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:47:29Z","timestamp":1789494449617,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.phrs.2018.10.031","type":"journal-article","created":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T11:58:44Z","timestamp":1541419124000},"page":"106-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study"],"prefix":"10.1016","volume":"139","author":[{"given":"M.","family":"Sabid\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hohenberger","family":"Thilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grassi","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2018.10.031_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1074248416679733","article-title":"Angina and its management","volume":"22","author":"Kloner","year":"2017","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2018.10.031_bib0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jcin.2014.01.157","article-title":"Angina pectoris and myocardial ischemia in the absence of obstructive coronary artery disease: practical considerations for diagnostic tests","volume":"7","author":"Radico","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"issue":"12","key":"10.1016\/j.phrs.2018.10.031_bib0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/CIRCULATIONAHA.107.720953","article-title":"Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries","volume":"117","author":"Hemingway","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2018.10.031_bib0020","series-title":"Cardiovascular Disease Statistics","author":"British Heart Foundation","year":"2014"},{"issue":"2","key":"10.1016\/j.phrs.2018.10.031_bib0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.CIR.90.2.762","article-title":"Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)","volume":"90","author":"Pepine","year":"1994","journal-title":"Circulation."},{"issue":"38","key":"10.1016\/j.phrs.2018.10.031_bib0030","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Task Force Members","year":"2013","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.phrs.2018.10.031_bib0035","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"Fihn","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.phrs.2018.10.031_bib0040","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2018.10.031_bib0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1741826711409325","article-title":"Long-term beta blockers for stable angina: systematic review and meta-analysis","volume":"19","author":"Shu de","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.phrs.2018.10.031_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0735-1097(94)00345-Q","article-title":"Medical treatment to reduce ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicentre trial comparing bisoprolol and nifedipine. The TIBBS investigators","volume":"25","author":"Arnim","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2018.10.031_bib0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0735-1097(94)00345-Q","article-title":"Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators","volume":"25","author":"von Arnim","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2018.10.031_bib0060","series-title":"Current Cardiovascular Drugs","author":"Frishman","year":"2005"},{"key":"10.1016\/j.phrs.2018.10.031_bib0065","series-title":"Pharmacotherapeutics for Advanced Practice: a Practical Approach","author":"Arcangelo","year":"2006"},{"issue":"6","key":"10.1016\/j.phrs.2018.10.031_bib0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/00003495-200565060-00006","article-title":"Optimising the use of beta-adrenoceptor antagonists in coronary artery disease","volume":"65","author":"Ellison","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2018.10.031_bib0075","unstructured":"Medicines and Healthcare products Regulatory Agency. MHRA PAR; Bisoprolol fumarate 1.25 mg, 2.5 mg, 5 mg and 10 mg tablets. In."},{"issue":"3","key":"10.1016\/j.phrs.2018.10.031_bib0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-5273(94)02194-N","article-title":"Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates","volume":"47","author":"van de Ven LL","year":"1995","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.10.031_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148349","article-title":"The impact of the choice of data source in record linkage studies estimating mortality in venous thromboembolism","volume":"11","author":"Gallagher","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2018.10.031_bib0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.phrs.2018.10.031_bib0095","unstructured":"Clinical Practice Research Datalink. Direct communication: EMIS data In.; 2017."},{"key":"10.1016\/j.phrs.2018.10.031_bib0100","series-title":"Census: Population and Household Estimates for England and Wales. In.; 2011","author":"Office for National Statistics","year":"2011"},{"issue":"9","key":"10.1016\/j.phrs.2018.10.031_bib0105","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/HJH.0000000000001382","article-title":"Exploring factors associated with patients\u2019 adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom","volume":"35","author":"Kurdi","year":"2017","journal-title":"J. Hypertens."},{"issue":"9","key":"10.1016\/j.phrs.2018.10.031_bib0110","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"issue":"9","key":"10.1016\/j.phrs.2018.10.031_bib0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","article-title":"Heart rate working G. Resting heart rate in cardiovascular disease","volume":"50","author":"Fox","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.phrs.2018.10.031_bib0120","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/2047487317695628","article-title":"The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis","volume":"24","author":"Du","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2018.10.031_bib0125","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"Ho","year":"2008","journal-title":"Am. Heart J."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818307394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818307394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:31:59Z","timestamp":1554460319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818307394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"alternative-id":["S1043661818307394"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.10.031","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}